Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
The purpose of this study is to determine if either a targeted type of talk therapy (Phase I) or medication, Wellbutrin, (Phase II) improve sleep disturbance and/or fatigue in individuals with Inflammatory Bowel Disease (IBD).
Epistemonikos ID: 9f05d36fa343228a53e7de6aa4577233342a6b21
First added on: Mar 23, 2022